share_log

Cantor Fitzgerald Reinstates Neutral on Humanigen, Announces $0.15 Price Target

Cantor Fitzgerald Reinstates Neutral on Humanigen, Announces $0.15 Price Target

坎托·菲茨杰拉德恢复对Humanigen的中立,宣布目标价为0.15美元
Benzinga Real-time News ·  2023/01/11 07:34

Cantor Fitzgerald analyst Louise Chen reinstates Humanigen (NASDAQ:HGEN) with a Neutral and announces $0.15 price target.

Cantor Fitzgerald分析师Louise Chen恢复Humanigen(纳斯达克:HGEN)中性,并宣布0.15美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发